Hospitalization for acute heart failure during non-working hours impacts on long-term mortality: the REPORT-HF registry.


Journal

ESC heart failure
ISSN: 2055-5822
Titre abrégé: ESC Heart Fail
Pays: England
ID NLM: 101669191

Informations de publication

Date de publication:
10 2023
Historique:
received: 05 07 2023
accepted: 10 08 2023
medline: 13 10 2023
pubmed: 31 8 2023
entrez: 31 8 2023
Statut: ppublish

Résumé

Hospital admission during nighttime and off hours may affect the outcome of patients with various cardiovascular conditions due to suboptimal resources and personnel availability, but data for acute heart failure remain controversial. Therefore, we studied outcomes of acute heart failure patients according to their time of admission from the global International Registry to assess medical practice with lOngitudinal obseRvation for Treatment of Heart Failure. Overall, 18 553 acute heart failure patients were divided according to time of admission into 'morning' (7:00-14:59), 'evening' (15:00-22:59), and 'night' (23:00-06:59) shift groups. Patients were also dichotomized to admission during 'working hours' (9:00-16:59 during standard working days) and 'non-working hours' (any other time). Clinical characteristics, treatments, and outcomes were compared across groups. The hospital length of stay was longer for morning (odds ratio: 1.08; 95% confidence interval: 1.06-1.10, P < 0.001) and evening shift (odds ratio: 1.10; 95% confidence interval: 1.07-1.12, P < 0.001) as compared with night shift. The length of stay was also longer for working vs. non-working hours (odds ratio: 1.03; 95% confidence interval: 1.02-1.05, P < 0.001). There were no significant differences in in-hospital mortality among the groups. Admission during working hours, compared with non-working hours, was associated with significantly lower mortality at 1 year (hazard ratio: 0.88; 95% confidence interval: 0.80-0.96, P = 0.003). Acute heart failure patients admitted during the night shift and non-working hours had shorter length of stay but similar in-hospital mortality. However, patients admitted during non-working hours were at a higher risk for 1 year mortality. These findings may have implications for the health policies and heart failure trials.

Identifiants

pubmed: 37649316
doi: 10.1002/ehf2.14506
pmc: PMC10567635
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3164-3173

Informations de copyright

© 2023 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

Références

Circ Heart Fail. 2016 Sep;9(9):
pubmed: 27623769
Circ Heart Fail. 2008 May;1(1):50-7
pubmed: 19808270
Chest. 2012 Sep;142(3):690-696
pubmed: 22459777
Int J Cardiol. 2017 Dec 15;249:292-300
pubmed: 28986059
Eur J Heart Fail. 2016 Aug;18(8):1041-50
pubmed: 27114058
Am Heart J. 2009 Sep;158(3):451-8
pubmed: 19699870
Eur Heart J Acute Cardiovasc Care. 2019 Aug;8(5):432-442
pubmed: 29498538
PLoS One. 2021 Nov 18;16(11):e0260152
pubmed: 34793535
Lancet Glob Health. 2020 Mar;8(3):e411-e422
pubmed: 32087174
Int J Cardiol. 2011 Nov 17;153(1):102-5
pubmed: 21968075
Am Heart J. 2017 May;187:62-69
pubmed: 28454809
Ann Thorac Surg. 2019 Sep;108(3):770-776
pubmed: 30953648
J Cardiol. 2013 Mar;61(3):210-5
pubmed: 23280417
JACC Heart Fail. 2021 May;9(5):349-359
pubmed: 33839078
Heart Fail Clin. 2015 Oct;11(4):581-9
pubmed: 26462098
ESC Heart Fail. 2023 Oct;10(5):3164-3173
pubmed: 37649316
JACC Heart Fail. 2014 Oct;2(5):429-36
pubmed: 25194294
JAMA Cardiol. 2020 Apr 1;5(4):401-410
pubmed: 31913404
Am Heart J. 2015 Aug;170(2):290-7
pubmed: 26299226
Emerg Med Australas. 2014 Aug;26(4):361-7
pubmed: 24934833
JACC Heart Fail. 2018 Apr;6(4):298-307
pubmed: 29525328
Int J Cardiol. 2018 Nov 15;271:98-104
pubmed: 29880299
N Engl J Med. 2001 Aug 30;345(9):663-8
pubmed: 11547721

Auteurs

Spyridon Katsanos (S)

Department of Emergency Medicine, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece.

Wouter Ouwerkerk (W)

National Heart Centre Singapore, Singapore.
Department of Dermatology, Amsterdam UMC, University of Amsterdam, Amsterdam Infection and Immunity Institute, Amsterdam, The Netherlands.

Dimitrios Farmakis (D)

Cardio-Oncology Clinic, Heart Failure Unit, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece.
University of Cyprus Medical School, Nicosia, Cyprus.

Sean P Collins (SP)

Department of Emergency Medicine, Vanderbilt University Medical Center and Geriatric Research and Education Center, Nashville VA, Nashville, TN, USA.

Christiane E Angermann (CE)

Department of Medicine 1, Comprehensive Heart Failure Center University and University Hospital Würzburg, Würzburg, Germany.

Kenneth Dickstein (K)

University of Bergen, Stavanger University Hospital, Stavanger, Norway.

Jasper Tomp (J)

Saw Swee Hock School of Public Health, National University of Singapore and the National University Health System, Singapore.
Duke-NUS Medical School, Singapore.
Yong Loo Lin School of Medicine, Singapore.

Georg Ertl (G)

Department of Medicine 1, Comprehensive Heart Failure Center University and University Hospital Würzburg, Würzburg, Germany.

John Cleland (J)

Robertson Centre for Biostatistics and Clinical Trials, Institute of Health and Well-Being, University of Glasgow, Glasgow, Scotland.
National Heart and Lung Institute, Imperial College, London, UK.

Ulf Dahlström (U)

Department of Cardiology, Linkoping University, Linkoping, Sweden.
Department of Health, Medicine and Caring Sciences, Linkoping University, Linkoping, Sweden.

Achim Obergfell (A)

Novartis Pharma AG, Basel, Switzerland.

Mathieu Ghadanfar (M)

M-Ghadanfar Consulting Life Sciences, Basel, Switzerland.

Sergio V Perrone (SV)

El Cruce Hospital by Florencio Varela, Lezica Cardiovascular Institute, Sanctuary of the Trinidad Miter, Buenos Aires, Argentina.

Mahmoud Hassanein (M)

Faculty of Medicine, Department of Cardiology, Alexandria University, Alexandria, Egypt.

Konstantinos Stamoulis (K)

Second Department of Cardiology, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Rimini 1 Chardairi, Athens, Greece.

John Parissis (J)

Department of Emergency Medicine, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Athens, Greece.

Carolyn Lam (C)

National Heart Centre Singapore, Singapore.
Duke-NUS Medical School, Singapore.

Gerasimos Filippatos (G)

Second Department of Cardiology, Attikon University Hospital, National and Kapodistrian University of Athens Medical School, Rimini 1 Chardairi, Athens, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH